UEVLD expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.139800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.227000E-01
Normal-vs-Stage2
6.480000E-01
Normal-vs-Stage3
2.681000E-01
Normal-vs-Stage4
3.915600E-01
Stage1-vs-Stage2
9.060600E-01
Stage1-vs-Stage3
1.451380E-01
Stage1-vs-Stage4
3.877000E-01
Stage2-vs-Stage3
1.215170E-01
Stage2-vs-Stage4
2.369200E-01
Stage3-vs-Stage4
1.571830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.479800E-01
Normal-vs-AfricanAmerican
5.200600E-01
Normal-vs-Asian
9.899000E-01
Caucasian-vs-AfricanAmerican
5.345800E-01
Caucasian-vs-Asian
5.606200E-01
AfricanAmerican-vs-Asian
3.453200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.089600E-01
Normal-vs-Female
7.227400E-01
Male-vs-Female
7.984000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.120600E-01
Normal-vs-Age(41-60Yrs)
4.761800E-01
Normal-vs-Age(61-80Yrs)
8.543000E-01
Normal-vs-Age(81-100Yrs)
9.128800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.128400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.478200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.263000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.088100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.572800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.306000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.508600E-01
Normal-vs-Daily Drinker
6.862800E-01
Normal-vs-Weekly Drinker
7.259800E-01
Normal-vs-Occasional Drinker
4.194600E-01
Normal-vs-Social Drinker
6.020800E-01
Non Drinker-vs-Daily Drinker
2.578600E-01
Non Drinker-vs-Weekly Drinker
3.813400E-01
Non Drinker-vs-Occasional Drinker
6.874300E-02
Non Drinker-vs-Social Drinker
2.906200E-01
Daily Drinker-vs-Weekly Drinker
8.648200E-01
Daily Drinker-vs-Occasional Drinker
2.373700E-02
Daily Drinker-vs-Social Drinker
8.451500E-02
Weekly Drinker-vs-Occasional Drinker
3.343700E-02
Weekly Drinker-vs-Social Drinker
1.453010E-01
Occasional Drinker-vs-Social Drinker
4.458400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.640750E-01
Normal-vs-Grade 2
4.552400E-02
Normal-vs-Grade 3
2.823900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.522500E-02
Grade 1-vs-Grade 3
3.202300E-02
Grade 1-vs-Grade 4
1.640750E-01
Grade 2-vs-Grade 3
3.711600E-01
Grade 2-vs-Grade 4
4.552400E-02
Grade 3-vs-Grade 4
2.823900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.204200E-01
Normal-vs-NonDiabetic
8.426200E-01
Diabetic-vs-NonDiabetic
7.565000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.501200E-01
Normal-vs-NoPancreatitis
8.168200E-01
Pancreatitis-vs-NoPancreatitis
4.084000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.804000E-01
Normal-vs-N1
6.601000E-01
N0-vs-N1
5.966400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.568600E-01
Normal-vs-TP53-NonMutant
7.255600E-01
TP53-Mutant-vs-TP53-NonMutant
1.636300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
